World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR1895
Date of registration: 06/07/2009
Primary sponsor: VU University Medical Center
Public title: Localized epilepsy and neural networks.
Scientific title: Lesional epilepsy: the effects of surgical intervention on ictal onset zone and permissive neural networks. - LESION
Date of first enrolment: 9/7/2009
Target sample size: 40
Recruitment status: pending
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1895
Study type:  observational
Study design:  Randomised: No; Masking: None; Control: Not applicable; Group: [default]; Type: Single arm  
Countries of recruitment
The Netherlands
Contacts
Name: E.  Dellen, van
Address:  Postbus 7057, Department of Neurology - ZH 1F.003/005 VU Medisch Centrum 1007 MB Amsterdam The Netherlands
Telephone: +31 (0)20-4444234
Email:
Affiliation: 
Name: E.  Dellen, van
Address:  Postbus 7057, Department of Neurology - ZH 1F.003/005 VU Medisch Centrum 1007 MB Amsterdam The Netherlands
Telephone: +31 (0)20-4444234
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria for pharmacoresistant epilepsy patients are:

1. Adult ( 18 years);

2. Patients who undergo resective surgical treatment at the VUmc regarding the Dutch Collaborative Epilepsy Surgery Program;

3. Have given written informed consent.



For brain tumour patients with epilepsy, inclusion criteria are:

1. Adult ( 18 years);

2. Patients who undergo resective surgical treatment of the tumour with epilepsy surgery techniques at the VUmc;

3. Are suffering from epilepsy which was not pre-existent to the lesion;

4. Have given written informed consent.

Exclusion criteria: Exclusion criteria are:

1. Psychiatric disease or symptoms;

2. Insufficient mastery of the Dutch language;

3. Inability to communicate adequately.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Glioma, Brain tumor, Epilepsy

Intervention(s)
N/A
Primary Outcome(s)
The main study parameters are a ECoG and MEG-based measures, assessing functional connectivity (SL and PLI) and neuronal brain networks (cluster coefficient and path length), seizure frequency and epilepsy burden.
Secondary Outcome(s)
Secondary ID(s)
NEF0909
Source(s) of Monetary Support
Netherlands Epilepsy Foundation (NEF)
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history